04.05.2021 • NewsHexion

Hexion Completes Phenolic Resins Sale

Hexion has completed the sale of its phenolic specialty resin, hexamine and European-based forest products resins businesses to private equity investors Investindustrial and Black Diamond Capital Management for about $425 million. The deal, which took effect after all approvals, was announced in September 2020.

Columbus, Ohio, USA-based Hexion, which supplies the global adhesive, coatings, composites and industrial markets, said it plans to use the proceeds to invest in its business and further reduce debt. CEO Craig Rogerson added that the sale strengthens the company’s balance sheet while maintaining a strong specialty chemical portfolio going forward.

Investindustrial is a European group of independently managed investment, holding and advisory companies with €11 billion of raised fund capital. Black Diamond based in Stamford, Connecticut, focuses on underwriting, trading, restructuring and managing stressed, distressed and private equity investments. Funds managed by the two investors own equal shares in Polynt-Reichhold, formed in 2017 from the merger between Italy’s Polynt and US-based Reichhold.

Author: Dede Williams, Freelance Journalist

Hexion has completed the sale of its phenolic specialty resin, hexamine and...
Hexion has completed the sale of its phenolic specialty resin, hexamine and European-based forest products resins businesses to private equity investors Investindustrial and Black Diamond Capital Management for $425 million. Proceeds will be reinvested and used to reduce debt. (c) Hexion

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
21.03.2025 • News

What’s Next for Pharma Supply Chains?

Sudden shifts in demand, supply shortages and global collapse have put immense pressure on pharmaceutical logistics. To address these challenges, PHARMAP 2025 brings together industry experts to discover AI-driven supply chain optimisation, strategic logistics partnerships and digital solutions that enhance efficiency and resilience in the pharmaceutical supply chain.